Charles Farkas - 05 Sep 2024 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Thomas Fistek for Charles Farkas by Power of Attorney
Issuer symbol
CNMD
Transactions as of
05 Sep 2024
Transactions value $
-$42
Form type
4
Filing time
09 Sep 2024, 10:46:46 UTC
Previous filing
04 Jun 2024
Next filing
06 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $39.6K +1K +5.03% $39.64 20.9K 05 Sep 2024 Direct
transaction CNMD Common Stock Tax liability -$39.7K -534 -2.56% $74.31 20.3K 05 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD SARs (Stock Appreciation Rights) Options Exercise $0 -1K -100% $0.00 0 05 Sep 2024 Common Stock 1K $39.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs vesting on June 1, 2015 and expiring on September 11, 2024.